カテゴリー: Publications(JP)

Tamura T#, Mizuma K#, Nasser H#, Deguchi S#, Padilla-Blanco M#, Uriu K#, Tolentino JEM# (#equal contribution), Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Jonathan M, Kosugi Y, Guo Z, Hinay Jr. AA, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Ito J, Irie T, Zahradnik J*, Ikeda T*, Takayama K*, Matsuno K*, Fukuhara T*, Sato K* (*equal correspondence).

Virological characteristics of the SARS-CoV-2 BA.2.86 variant.

Cell Host Microbe.

Click for more details　→

Jonathan M, Ikeda T* (*correspondence)

APOBEC3 family proteins as drivers of virus evolution

Front Virol

Front Virol DOI : https://doi.org/10.1016/j.chom.2024.01.001

詳しくはこちら　→

Nozomi Kuse, Hiroyuki Gatanaga, Yu Zhang, Takayuki Chikata, Shinichi Oka, and Masafumi Takiguchi, Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8+ T cells. J. Virol. 97: e0102423, 2023

→詳しくはこちら

Takayuki Chikata, Hiroyuki Gatanaga, Hung The Nguyen, Daisuke Mizushima, Yu Zhang, Nozomi Kuse, Shinichi Oka, and Masafumi Takiguchi, HIV-1 protective epitope-specific CD8+ T cells in HIV-1-exposed seronegative individuals. iScience 26: 108089, 2023

→詳しくはこちら

Emmanuel Nkuwi, George P. Judicate, Toong Seng Tan, Godfrey Barabona, Mako Toyoda, Bruno Sunguya, Doreen Kamori, Takamasa Ueno.Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity

Journal of Virology DOI: 10.1128/jvi.00823-23

Ikeda T#,* (*correspondence), Shimizu R# (#equal contribution), Nasser H, Carpenter MA, Cheng AZ, Brown WL, Sauter D, Harris RS.

APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.

mBio

mBio→

 

Mako Toyoda, Toong Seng Tan, Chihiro Motozono, Godfrey Barabona, Akiko Yonekawa, Nobuyuki Shimono, Rumi Minami, Yoji Nagasaki, Yusuke Miyashita, Hiroyuki Oshiumi, Kimitoshi Nakamura, Shuzo Matsushita , Takeo Kuwata, Takamasa Ueno.Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay. https://doi.org/10.1128/spectrum.00660-2

Microbiology Spectrum→

Tamura T#, Ito J#, Uriu K#, Zahradnik J#, Kida I#, Anraku Y, Nasser H#, Shofa M#, Oda Y#, Lytras S# (#equal contribution), Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Lin P, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S*, Matsuno K*, Takayama K*, Sato K* (*equal correspondence).

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

Nature Communications　→